The committee will recommend further course of action to the Drugs Controller General of India after examining and analysing the adverse event reports...
India's drug regulator Drugs Controller General of India has already initiated a probe and sought further details from the World Health Organisation...
The Hyderabad-based firm completed clinical trials of the nasal vaccine with about 4,000 volunteers and there is no side effect or adverse reaction reported so far...